ADC Therapeutics SA (ADCT) vs Outlook Therapeutics, Inc. (OTLK)
ADC Therapeutics SA and Outlook Therapeutics, Inc. are both Biotechnology companies. ADC Therapeutics SA and Outlook Therapeutics, Inc. are of similar size ($164.7M and $159.5M). ADC Therapeutics SA grew revenue faster over the last twelve months: 3.03% against −113.6%. Outlook Therapeutics, Inc. has the higher net margin (5,253.4% vs −121.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Outlook Therapeutics, Inc. leads on 9 and ADC Therapeutics SA on 6.
Valuation
Profitability
| Metric | ADCT | OTLK | Biotechnology median |
|---|---|---|---|
| Gross margin | 88.86% | 195.62% | 65.16% |
| Operating margin | (125.08%) | 4,781.76% | 0.00% |
| Net margin | (121.77%) | 5,253.40% | 0.00% |
| Free cash flow margin | (127.72%) | 4,826.38% | 0.00% |
| Return on equity | 45.35% | 256.92% | (57.72%) |
| Return on assets | (32.25%) | (251.66%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack